Cargando…

剂量调整的EP(D)OCH方案联合利妥昔单抗治疗新诊断双表达淋巴瘤的疗效分析

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342966/
https://www.ncbi.nlm.nih.gov/pubmed/28655103
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.06.017
_version_ 1783555650402385920
collection PubMed
description
format Online
Article
Text
id pubmed-7342966
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73429662020-07-16 剂量调整的EP(D)OCH方案联合利妥昔单抗治疗新诊断双表达淋巴瘤的疗效分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2017-06 /pmc/articles/PMC7342966/ /pubmed/28655103 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.06.017 Text en 2017年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
剂量调整的EP(D)OCH方案联合利妥昔单抗治疗新诊断双表达淋巴瘤的疗效分析
title 剂量调整的EP(D)OCH方案联合利妥昔单抗治疗新诊断双表达淋巴瘤的疗效分析
title_full 剂量调整的EP(D)OCH方案联合利妥昔单抗治疗新诊断双表达淋巴瘤的疗效分析
title_fullStr 剂量调整的EP(D)OCH方案联合利妥昔单抗治疗新诊断双表达淋巴瘤的疗效分析
title_full_unstemmed 剂量调整的EP(D)OCH方案联合利妥昔单抗治疗新诊断双表达淋巴瘤的疗效分析
title_short 剂量调整的EP(D)OCH方案联合利妥昔单抗治疗新诊断双表达淋巴瘤的疗效分析
title_sort 剂量调整的ep(d)och方案联合利妥昔单抗治疗新诊断双表达淋巴瘤的疗效分析
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342966/
https://www.ncbi.nlm.nih.gov/pubmed/28655103
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.06.017
work_keys_str_mv AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī
AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī
AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī
AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī
AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī
AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī
AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī
AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī
AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī
AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī
AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī
AT jìliàngdiàozhěngdeepdochfāngànliánhélìtuǒxīdānkàngzhìliáoxīnzhěnduànshuāngbiǎodálínbāliúdeliáoxiàofēnxī